Cindy Jacobs
2020
In 2020, Cindy Jacobs earned a total compensation of $773.9K as President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $159,580 |
---|---|
Option Awards | $194,091 |
Salary | $420,231 |
Total | $773,902 |
Jacobs received $420.2K in salary, accounting for 54% of the total pay in 2020.
Jacobs also received $159.6K in non-equity incentive plan and $194.1K in option awards.
Rankings
In 2020, Cindy Jacobs' compensation ranked 9,621st out of 13,090 executives tracked by ExecPay. In other words, Jacobs earned more than 26.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,621 | 27th |
Manufacturing | 4,131 | 27th |
Chemicals And Allied Products | 1,688 | 25th |
Drugs | 1,480 | 24th |
In Vitro and In Vivo Diagnostic Substances | 42 | 30th |
Jacobs' colleagues
We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2020.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019